Authors

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists

GLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.

Pharmacy Is a Practice, Not Just a Place

Pharmacy's location-based title reflects an unfinished professional transition that provider status and privileging, not renaming, must complete.

More Options, More Questions: How Pharmacists Are Managing EGFR-Positive Non-Small Cell Lung Cancer

Shelby Quinn, PharmD, BCOP shares insights about treatment using osimertinib in early lines.

Medication Management and Supply Chain Still Underwater: Challenges and Future Trends in Health Care

ADA Standards of Care: Beyond the Classroom

What began as a question about duplicative therapy ultimately led to a patient-specific intervention, the development of a tool for communicating recommendations, and a resource now available to pharmacists.

From Inpatient to Outpatient: A Pharmacy-Led Evolution in Transplant Care

Erin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.

How Medication Stigma and Bias Can Impact Patient Recovery

Pharmacy Times interviews Allison Burns, PharmD, RPh, the CEO of End Mass Overdose (EMO) Health to discuss how medication stigma and bias can impact patient recovery.

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

Pharmacists Leading the Treatment of Multiple Myeloma: Precision Therapy and Collaborative Oncology Care

Evolving myeloma therapies and pharmacist-led care reshape outcomes, tackling resistance, toxicity, and personalized treatment sequencing.

What Real-World Data Show About Moving Patients From Humira to Biosimilars

Data show adalimumab biosimilars can replace brand-name treatment with minimal gaps, high persistence, and sharply lower drug costs for patients and plans.

Improve Skin Health Through Student Pharmacist Education

Student pharmacists boost dermatology literacy in underserved communities, improving sunscreen habits, skin cancer warning recognition, and practical skin health self-care.

For Optimal Bioavailability, Administer Dronedarone With a Complete Meal

Bioavailability of dronedarone is markedly increased when administered with food. To maximize absorption, patients should take dronedarone with a complete meal (ideally >500 calories).

ADA 2026: Key Challenges in Optimizing Cardio-Renal Risk in Diabetes

Pharmacy Times interviews Tracey Taveira, Pharm.D., CDOE, CVDOE, on the key challenges she discovered in optimizing cardio-renal risk in diabetes that she presented in ADA 2026.

The Future of GLP-1 Therapies: Hype, Evidence, and the Expanding Role of Pharmacists

In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Donald Langan, PharmD, MD, a Multiple Sclerosis and Clinical Neuroimmunology Fellow at Columbia University, presenting on the evolution of GLP-1 receptor agonists, discussed the future of GLP-1 therapies and the expansion of the pharmacist's role.

Pharmacist-Led BiTE Program at a Community Cancer Center

Cone Health Cancer Center pharmacists lead bispecific T-cell engager rollout, boosting local access to care.

Op-Ed: FTC Adds Fuel to the Fire for PBMs. Will Congress Deliver Real Reform?

The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board for a different approach.

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.

Promising Phase 2 and 3 Influenza Therapies: What Pharmacists Should Know

Explore emerging flu antivirals, from season-long CD388 prevention to single-dose therapies, designed to beat current treatment limits.

STArT Investigator Explains Why Sickle Cell Pain Outcomes Vary Across Patients and Hospitals

In an interview with Pharmacy Times, Claudia R. Morris, MD, lead investigator and author of the phase 3 STArT trial and a pediatric emergency medicine physician at Children’s Healthcare of Atlanta, discussed how patient history and institutional pain-management practices may influence time to crisis resolution and how care teams, including pharmacists, can help standardize treatment.

Real-World Evidence Helps Accelerate Formulary Decisions for Biologics

Pharmacist Interventions Impact Bottom Line in a Neurology Clinic

Neurology pharmacists drive safer medication changes, boost access and financial assistance, and deliver major cost savings through high-impact outpatient pharmacist intervention.

Depression May Be an Early Manifestation of Neurodegenerative Changes Leading to Movement Disorders

Recent research links depression to increased risk of Lewy body dementia and Parkinson disease, emphasizing the need for early detection and awareness.

COVID-19 Variant Surveillance: A Primer for Pharmacists Navigating Vaccine Questions

Pharmacists play a key role in translating COVID-19 variant surveillance data into patient-centered counseling on vaccine efficacy.

How Registry Integration Helped One Pharmacist Avoid an Unnecessary Vaccine—and Build Patient Trust

Integrated access to the state immunization registry helped a Discount Drug Mart pharmacist avoid an unnecessary pneumococcal vaccine and strengthen patient trust.

Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists

These recommendations for acute pulmonary embolism management are most applicable to pharmacists on the interdisciplinary team managing acute PE.

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

Tenapanor offers a new approach to managing hyperphosphatemia in dialysis patients, balancing effectiveness with pill burden and cost considerations.

Op-Ed: Why Banning PBM-Owned Pharmacies Risks Patient Care

State policymakers should target bad actors while protecting access.

Beyond the Finish Line: Why the Pharmacy of Tomorrow is a Patient Journey, Not a Prescription Fill

With user expectations changing and the need to support patients throughout their entire treatment journey, growing technology-enabled communication allows pharmacists to build stronger relationships and go beyond prescription fill.

A Practical Guide to Peer Review in Pharmacy Practice

A review offering guidance to pharmacists on the importance of peer review as well as a tutorial on how to perform and respond to peer review.

The Role of the Pharmacist in the Management of Psychosis in Parkinson Disease

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.